Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Boris Jančar) .

1 - 10 / 26
Na začetekNa prejšnjo stran123Na naslednjo stranNa konec
1.
Acrospiroma of the left temporal region
Boris Jančar, 2009, drugi sestavni deli

Objavljeno v DiRROS: 08.03.2024; Ogledov: 54; Prenosov: 20
.pdf Celotno besedilo (433,26 KB)

2.
Extensive squamous cell carcinoma of the lower lid
Boris Jančar, 2008, strokovni članek

Objavljeno v DiRROS: 08.03.2024; Ogledov: 65; Prenosov: 20
.pdf Celotno besedilo (99,83 KB)

3.
Planocellular carcinoma of the right cheek
Boris Jančar, 2008, strokovni članek

Objavljeno v DiRROS: 07.03.2024; Ogledov: 67; Prenosov: 19
.pdf Celotno besedilo (227,74 KB)

4.
Basal cell carcinoma in the inner canthus
Boris Jančar, 2007, drugi sestavni deli

Objavljeno v DiRROS: 22.02.2024; Ogledov: 143; Prenosov: 20
.pdf Celotno besedilo (73,71 KB)

5.
Recurrence of carcinoma of the lower lip treated by interferon and irradiation
Boris Jančar, 2007, strokovni članek

Objavljeno v DiRROS: 21.02.2024; Ogledov: 395; Prenosov: 31
.pdf Celotno besedilo (97,73 KB)

6.
Mb. Bowen and squamous-cell carcinoma on the eczematous skin
Boris Jančar, 2007, strokovni članek

Objavljeno v DiRROS: 20.02.2024; Ogledov: 95; Prenosov: 20
.pdf Celotno besedilo (131,84 KB)

7.
Basal cell carcinoma on the left cheek
Boris Jančar, 2007, strokovni članek

Objavljeno v DiRROS: 20.02.2024; Ogledov: 94; Prenosov: 25
.pdf Celotno besedilo (1,83 MB)

8.
Carcinoma of the lower lip
Boris Jančar, 2006, strokovni članek

Objavljeno v DiRROS: 15.02.2024; Ogledov: 112; Prenosov: 19
.pdf Celotno besedilo (1,03 MB)

9.
Preoperative concomitant chemoradiotherapy in esophageal cancer
Boštjan Šeruga, Mihael Sok, Janez Eržen, Jože Jerman, Boris Jančar, Branko Zakotnik, 2006, izvirni znanstveni članek

Povzetek: Background. Currently primary treatment options for esophageal cancer are surgery only or concomitant chemoradiotherapy (CRT) and the long-term survivalof patients with locally advanced disease is rare. Preoperative concomitant CRT seems to be beneficial, mostly in patients who achieve a complete pathologic response (pCR) after CRT. In this retrospective analysis the efficiency and toxicity of preoperative CRT in patients with locally advanced esophageal cancer was analysed as well as the influence of pCR on thesuraival. Patients and metkods From 1996 to 2002 41 patients with locoregionally confined esophageal cancerwere treated with cisplatin 75 mgžm2 and 5-FU 1000 mgžm2 as 4 day contonuous infusion starting on days 1. and 22. with concorrtitant radiotherapy 4500 cGy, 200-300 cGyžday. Esophagectomy followed 4-5 weeks after radiotherapy. After the surgery patients were followed-up regularly at 3-6 months intervals. Results. The pCR was achieved in 26.8% of patients. The overall median survival time was 18 months for all patients, 21.2 months for patients who achieved pCR and 16 months in those with residual disease (p= 0,79). Postoperative mortality rate was 22%. The median dose intensity for cisplatin was 92% and for 5-FU 71.5 of the planned dose. Disease recurred most often locoregionally (31.7%) and the overall recurrence rate was 43.9. Conclusion. Modern radiation techniques and the adequate dose intensity could further improve the locoregional control. The selection of patients without comorbid conditions and without already present distant metastases is essential for this combined treatment approach.
Objavljeno v DiRROS: 15.02.2024; Ogledov: 101; Prenosov: 25
.pdf Celotno besedilo (123,83 KB)

10.
Brachytherapy (Ru 106) in the treatment of malignant melanoma of the choroid
Boris Jančar, K... Andrejčič, Primož Logar, Irena-Hedvika Brovet-Zupančič, 1997, objavljeni povzetek znanstvenega prispevka na konferenci

Objavljeno v DiRROS: 18.01.2024; Ogledov: 145; Prenosov: 35
.pdf Celotno besedilo (1,10 MB)

Iskanje izvedeno v 0.27 sek.
Na vrh